Focus on cardiovascular disease prevention and treatment The 11th China Hypertension Conference held

Chinanews.
com, Beijing, November 28th.
On the 27th, the 11th China Hypertension Conference (2021) of the Chinese Medical Doctor Association was opened online.
The participating experts conducted in-depth discussions on the current status, trends, and prevention and treatment of cardiovascular diseases in China.
Explore exchanges
.

The conference by the Chinese Medical Association, Chinese Medical Association Professional hypertension committee will be organized by the Chinese Medical Society of Cardiology, China Association of Medical Education hypertension committee will co-host, host the Second Affiliated Hospital of Chongqing Medical University
.

Vice president of the Chinese Medical Association, Yang Min, Zhongshan Hospital, director of Cardiology Junbo Ge academician , vice president of Dongfeng Gu proxy South University of Technology Academy of Sciences , Chinese Medical Association hypertension professional committee will be director of the committee Sunying Xian, Chinese Medical Association Professional hypertension committee will the first director of the committee Zhaolian You, vice president of Chongqing Medical University, Yuan Jun, second Affiliated hospital of Chongqing Medical University Party committee secretary T.
], attended the opening ceremony
.

Ge Junbo said at the conference that there are nearly 300 million people with hypertension in China, and the average annual cost of treatment of cardiovascular and cerebrovascular diseases is increasing at an annual rate of 10%, and the burden of cardiovascular disease in China is huge
.

Ge Junbo gave a keynote report entitled "Development and Prospects of Panvascular Medicine"
.

Gu Dongfeng said at the conference that since the country launched a series of macro policies such as the "Healthy China Strategy" and the "Healthy China 2030" Planning Outline, China's cardiovascular disease prevention and control have important institutional guarantees, including hypertension, diabetes, etc.
The prevention and treatment of diseases is also changing from disease treatment to prevention of risk factors
.

He said that in the future, on the one hand, we should strengthen the integration of Internet wearables, health management and other technologies, and promote a new cardiovascular disease management model; on the other hand, we should further improve the academic level and the training of hypertension prevention and treatment talents, especially primary hypertension.
The training of medical personnel for prevention and treatment will ultimately realize the precise prevention and control of cardiovascular diseases
.

Zhao Lianyou said that in recent years, China has made great progress in the prevention and control of hypertension, but the prevalence, disability and fatality rates of hypertension in China are still maintained at a high level, and the cost of hypertension treatment is also increasing year by year
.

He said that in the future, we should build a new hypertension prevention and control system with government leadership, medical care as the mainstay, and participation of social groups and patients; strengthen the construction of hypertension prevention and treatment personnel, especially the training of basic hypertension talents; pay attention to standardization and individualization Hypertension treatment; promote standardized hypertension management mode, highlight the first-line role of primary medical institutions in hypertension management, and finally realize the full implementation of national policies
.

According to the organizer, the main theme of this conference is "inheritance, innovation, intelligence, cross-border, and sharing", with a view to promoting the scientific evaluation, diagnosis and treatment innovation, scientific management and system construction of China's hypertension
.